Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

4P5Z

Human EphA3 Kinase domain in complex with quinoxaline derivatives

Summary for 4P5Z
Entry DOI10.2210/pdb4p5z/pdb
DescriptorEphrin type-A receptor 3, 2-amino-1-[4-({[3-(trifluoromethyl)phenyl]carbamoyl}amino)phenyl]-1H-pyrrolo[2,3-b]quinoxaline-3-carboxamide (3 entities in total)
Functional Keywordstransferase, transferase inhibitor
Biological sourceHomo sapiens (Human)
Cellular locationIsoform 1: Cell membrane; Single-pass type I membrane protein. Isoform 2: Secreted: P29320
Total number of polymer chains1
Total formula weight40963.63
Authors
Dong, J.,Caflisch, A. (deposition date: 2014-03-20, release date: 2014-08-13, Last modification date: 2023-12-20)
Primary citationUnzue, A.,Dong, J.,Lafleur, K.,Zhao, H.,Frugier, E.,Caflisch, A.,Nevado, C.
Pyrrolo[3,2-b]quinoxaline Derivatives as Types I1/2 and II Eph Tyrosine Kinase Inhibitors: Structure-Based Design, Synthesis, and in Vivo Validation.
J.Med.Chem., 57:6834-, 2014
Cited by
PubMed Abstract: The X-ray crystal structures of the catalytic domain of the EphA3 tyrosine kinase in complex with two type I inhibitors previously discovered in silico (compounds A and B) were used to design type I1/2 and II inhibitors. Chemical synthesis of about 25 derivatives culminated in the discovery of compounds 11d (type I1/2), 7b, and 7g (both of type II), which have low-nanomolar affinity for Eph kinases in vitro and a good selectivity profile on a panel of 453 human kinases (395 nonmutant). Surface plasmon resonance measurements show a very slow unbinding rate (1/115 min) for inhibitor 7m. Slow dissociation is consistent with a type II binding mode in which the hydrophobic moiety (trifluoromethyl-benzene) of the inhibitor is deeply buried in a cavity originating from the displacement of the Phe side chain of the so-called DFG motif as observed in the crystal structure of compound 7m. The inhibitor 11d displayed good in vivo efficacy in a human breast cancer xenograft.
PubMed: 25076195
DOI: 10.1021/jm5009242
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.002 Å)
Structure validation

226707

数据于2024-10-30公开中

PDB statisticsPDBj update infoContact PDBjnumon